A vaccine? Travel stocks to lift on successful drug trial

A vaccine? Travel stocks to lift on successful drug trial
Rebecca Howard
Successful data from a late-stage covid-19 vaccine trial will give beleaguered travel stocks including Air New Zealand and Auckland International Airport a lift, as well as companies with direct exposure to foreign visitors like SkyCity Entertainment Group.Wall Street — already pushing higher on Joe Biden’s win — jumped when US drugmaker Pfizer and its German partner BioNTech said data from the large-scale trial of their vaccine showed it was more than 90 percent effective in preventing covid-19.“We are reaching this cri...

More Markets

NZ sharemarket drops as US market rallies
Markets Market Close

NZ sharemarket drops as US market rallies

The S&P/NZX 50 Index closed down 1.02% or 122.14 points.

Radius buys care home off Arvida
Property

Radius buys care home off Arvida

Radius Care will have another 109 beds in Christchurch.

‘It really is upwards from here,’ Pacific Edge CEO
Markets

‘It really is upwards from here,’ Pacific Edge CEO

The AUA’s guideline has made Pacific Edge’s tests a talking point. 

Airports v airlines and the regional monopoly conundrum
Policy Analysis

Airports v airlines and the regional monopoly conundrum

Why is airport regulation being reviewed when all the fuss is about airfares?